ALMR
Alamar Biosciences, Inc.
A biotech company that makes ultra-sensitive tools for measuring proteins in blood and other samples. Its NULISA platform lets researchers spot tiny amounts of disease-linked proteins, helping with early cancer detection and drug development. Founded in 2018 by Yuling Luo, who previously co-founded Advanced Cell Diagnostics, Alamar is based in Fremont, California, and grew out of the "next chapter" of ultra-sensitive molecular detection work.
CUSIP: 010911105HealthcareUS2 holders
Recent Activity
2026Q2
2 buys
+596.6K shares
+596.6K shares
+1.37M shares
ARK InvestNEW
+1.37M shares